Efficacy Observation on Gubi Prescription for Kidney Deficiency and Blood Stasis Type Knee Osteoarthritis and Its Effect on Articular Cartilage in High Frequency Ultrasound
|更新时间:2024-01-04
|
Efficacy Observation on Gubi Prescription for Kidney Deficiency and Blood Stasis Type Knee Osteoarthritis and Its Effect on Articular Cartilage in High Frequency Ultrasound
Chinese Journal of Experimental Traditional Medical FormulaeVol. 23, Issue 8, Pages: 166-172(2017)
JIANG Yu-bao, LIN Chang-song, LI Nan, et al. Efficacy Observation on Gubi Prescription for Kidney Deficiency and Blood Stasis Type Knee Osteoarthritis and Its Effect on Articular Cartilage in High Frequency Ultrasound[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(8): 166-172.
DOI:
JIANG Yu-bao, LIN Chang-song, LI Nan, et al. Efficacy Observation on Gubi Prescription for Kidney Deficiency and Blood Stasis Type Knee Osteoarthritis and Its Effect on Articular Cartilage in High Frequency Ultrasound[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(8): 166-172. DOI: 10.13422/j.cnki.syfjx.2017080166.
Efficacy Observation on Gubi Prescription for Kidney Deficiency and Blood Stasis Type Knee Osteoarthritis and Its Effect on Articular Cartilage in High Frequency Ultrasound
Objective: To observe the clinical effect of Gubi prescription on kidney deficiency and blood stasis type knee osteoarthritis (KOA) and investigate its protective function for articular cartilage. Method: The 86 cases of KOA patients who met the requirements from the department of rheumatology outpatient clinic in the First Affiliated Hospital of Guangzhou University of Chinese Medicine since June 2015 to February 2016 were divided into 2 groups according to the random number table method. Patients in control group (43 cases) orally took glucosamine hydrochloride capsules
and patients in treatment group (43 cases) orally took Gubi prescription on the basis of the treatment in control group. The course of treatment was 12 weeks in both groups. Before treatment and 4
8
12 weeks after treatment
the Lequesne index and knee joint motion function tests were performed in patients to grade the knee joint symptoms
functions and quality of life
and their articular cartilage
synovial membrane and joint effusion were evaluated by high frequency ultrasound. In addition
their clinical curative effects were compared and adverse reactions were recorded. Result: The clinical efficacy was 95.12% in treatment group
higher than 77.5% in control group (P<0.05)
the treatment group could more quickly improve the Lequesne index score
knee function and reduce the joint synovial thickness
fluid volume
and blood flow signal strength
because after treatment
the above indexes in treatment group were better than those in control group (P < 0.05
P < 0.01). The thickness of articular cartilage was not significantly improved in both groups
and the thickness of cartilage of medial femoral condyle in treamtnet group was larger than that in control group
but there was no significant difference between the two groups. Conclusion: Gubi prescription can effectively improve the clinical symptoms and the knee joint function of the patients with knee osteoarthritis